Source: WESTERN UNIVERSITY OF HEALTH SCIENCES submitted to NRP
WESTERNU CVM FORMULA FUNDING COMPETITIVE GRANT PROJECT
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1005019
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Oct 1, 2014
Project End Date
Sep 30, 2015
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
WESTERN UNIVERSITY OF HEALTH SCIENCES
309 EAST SECOND STREET
POMONA,CA 91766
Performing Department
CVM
Non Technical Summary
The WesternU CVM Formula Funding Competitive Grant Project is designed to support initiatives by CVM faculty in Animal Health research relevant to USDA goals. The nature of the impact of these projects on animal health is therefore specific to the project.Non Technical Summary for Project 1: "Conditioned Equine Umbilical Cord Derived Stem Cells for Tendon Repair"Stem cells have gained tremendous interest in the equine community because they offer new strategies to manage diseases that challenge traditional therapeutic approaches. Among these, tendon injury is one of the most common causes of wastage in the performance horse. Long-term prognosis for return to athletic use after flexor tendon injuries is guarded due to slow and incomplete healing, leading to re-injury in up to 67% of horses treated conservatively. Stem cell therapy in horses currently requires collection of cells from the patient, and is therefore limited by the patient's health status, delay due to processing, cost, and morbidity associated with collection. Stem cells obtained from the placenta during normal foaling are appealing as an alternative, because they avoid ethical concerns associated with the destruction of embryos, and are privileged compared to stem cells derived from adult tissues.In this project, we will test a conditioning technique to improve the properties of these cells in tendon injuries. We will inject stem cells with and without conditioning into experimental tendon defects in rats. The presence of cells in the tissues will be evaluated 7 and 28 days after injection. We will confirm that the cells stay in the defect without side effects, and contribute to the healing of tendons at 7 and 28 days after injection. We will also compare the strength of the tendons injected with conditioned or regular stem cells after 28 days. Ultimately, we expect to identify a cost effective, off-the-shelf option for stem cell therapy in horses that may eventually become applicable to other species.Non technical summary for Project 2: "Epidemiologic Insight into Toxoplasmosis in Southern California: A One Health Study"The aim of this project is to study the environmental factors that enable transmission of toxoplasmosis in Southern California and how it can be better prevented, using a collaborative approach.There is currently no screening program for congenital toxoplasmosis in the USA, due to the perceived low exposure to the parasite, compared to some European countries. However, Southern California may be different from most of the USA, due to immigration and the proximity with livestock in Baja California. Backyard livestock and cats may be infected and this may compromise the health of the new born and immuno-compromised people. We anticipate the prevalence is likely higher than the rest of the country.We propose to determine the frequency of the infection in people and animals in small suburban/urban ("backyard") farms in the Chino Valley area of Southern California. We will also assess the risk factors within both the animals and the associated human populations. We will study these same aspects in individuals who would likely be exposed to the same environmental factors as the farmers but not those risk factors associated with farming. These will be student, faculty and staff from Western University of Health Sciences. We will compare the risk factors in both populations in order to understand the health determinants and drivers of toxoplasmosis regionally.Successful prevention should be dictated by an understanding of the ecology of this disease. We believe that the findings of this project will help provide evidence for better prevention measures and save human lives, and help decision makers tailor appropriate prevention measures.
Animal Health Component
50%
Research Effort Categories
Basic
0%
Applied
50%
Developmental
50%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
3113810113050%
7226099111050%
Goals / Objectives
The overall goals are to: 1) enhance students' exposure to research and improve their awareness of USDA relevant issues; and 2) discover new knowledge that will improve animal and/or human health. We intend to achieve these goals by supporting specific projects proposed by WesternU, College of Veterinary Medicine faculty members engaged in research relevant to USDA's mission.USDA funds currently support two short term projects focusing on: 1) "Conditioned Equine Umbilical Cord Derived Stem Cells for Tendon Repair"; and 2) "Epidemiologic Insight into Toxoplasmosis in Southern California: A One Health Study"The 2014-2015 Formula Funds are expected to support additional projects. A call has been sent for applications within the scope of USDA, with a deadline of October 1, 2014. Proposals will be chosen by the CVM Research Advisory Committee for funding, but will be designed for completion within a year. They are intended to support further initiatives in Animal Health research as a seed grant in support of a larger USDA, or similar organization, grant proposal or for immediate publication (within 12 months of project completion) to peer-reviewed Animal Health scientific journals.
Project Methods
Methods for Project 1: "Conditioned Equine Umbilical Cord Derived Stem Cells for Tendon Repair"Our long term goal is to develop a cell population with enhanced stemness for allogenic regenerative therapy in horses. Based on published evidence and preliminary data, stem cells derived from equine umbilical cord matrix (eqUCM-MSCs) cultured under hypoxia on chitosan film form spheroids and display enhanced potential for self-renewal and multi-lineage differentiation in vitro. We now hypothesize that these properties will translate into superior tissue healing in vivo. We will test our central hypothesis by pursuing two specific aims: 1) to determine the influence of conditioning eqUCM-MSCs on 1- the biocompatibility and retention of cells in injured tendons; and 2) the healing of injured tendons. We will pursue these objectives by testing two hypotheses:-Conditioned eqUCM-MSCs will improve healing of an injured tendon compared to non-conditioned cells. We will test this hypothesis by comparing the histopathological appearance and biomechanical properties of patellar tendon defects 7 and 28 days after injection of eqUCM-MSCs cultured on a chitosan film and hypoxia versus standard conditions.-We will compare the tensile properties, the presence of fluorescent cells and the histological features of experimental tendon defects in rats, 7 and 28 days after injection of activated platelet rich plasma containing labeled eqUCM-MSCs cultured on a chitosan film under hypoxia versus standard conditions (control group). We expect that conditioning eqUCM-MSCs with chitosan and hypoxia will improve tendon healing without inducing side effects in rats.Methods for Project 2: "Epidemiologic Insight into Toxoplasmosis in Southern California: A One Health Study"Specific Aim 1: To test if T. gondii infection is prevalent in animals in Southern California.The objective of this study is to determine the seroprevalence of Toxoplasma gondii antibodies in pigs, sheep, goats, and cattle in small suburban/urban ("backyard") farms in the Chino Valley area of Southern California. The potential public health exposure of zoonotic diseases has not been investigated in this population of animals in Southern California and the data generated from this project will be valuable in assessing risks within both the animals and the associated human populations.This is a cross-sectional study looking at the seroprevalence of T. gondii in pigs, sheep, goats and cattle. Farms in the Chino Valley area will be identified. Samples for various livestock species will be tested for Toxoplasma antibodies and the results will be used to estimate the seroprevalence of T. gondii. A survey form will be completed for each farm to allow analysis by livestock species, farm size, and estimates of human exposure. A questionnaire will be used to explore the risk factors associated with infection in livestock. Odds ratios and prevalence ratios will be calculated to estimate the measure of association between various on-farm exposure factors and disease.Seroprevalence data and farm description data will be used to generate estimated risk for human exposure to T. gondii and potential infection.Specific Aim 2: to test if T. gondii seroprevalence in farmers differs from non farmers in Southern California.The objective of this study is to determine the seroprevalence of T. gondii in farmers in the Chino Valley area of Southern California and to draw comparisons with the seroprevalence in a population of non-farmers from the same region. Two human populations will be sampled: workers at the livestock holdings identified above and volunteers from Western University of Health Sciences. The WesternU community will be representative of individuals who would likely be exposed to the same environmental factors as the farmers but not those risk factors associated with farming.Serum samples will be tested for Toxoplasma antibodies using the Modified Agglutination Test. A survey will be used to determine the risk factors associated with the disease/infection. Comparison of the prevalence in the 2 study populations (WesternU and farms) will help us determine the importance of risk factors associated with farming. Odds ratios and prevalence ratios will be calculated to estimate the measure of association between various exposure factors and disease. The surveys will help us identify risk factors associated with Toxoplasma infection in both groups.

Progress 10/01/14 to 09/30/15

Outputs
Target Audience:Title: Genome sequencing of novel Clostridial isolates with probiotic potential Primarily academic with knowledge transfer to industry. Title: Macrophage priming affects disease resistance and susceptibility in response to viral pathogens. Academic Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?Title: Genome sequencing of novel Clostridial isolates with probiotic potential Training of lab technicians in bacterial culture and DNA extraction protocols. Title: Macrophage priming affects disease resistance and susceptibility in response to viral pathogens. Mr. Jory Clark, who started his Master Thesis on this project is on target to finish his experiments in the early summer of 2016, graduating by fall. He has successfully mastered various laboratory techniques during this project, such as isolation of mononuclear cells, cell culture and differentiation, RNA isolation, cDNA synthesis, RealTime PCR in addition to data analysis and has already been included in the submission of one of our manuscripts (under review). Mr. Clark also successfully applied to Western University's Veterinary College and will start his DVM studies fall of 2016. How have the results been disseminated to communities of interest?Title: Genome sequencing of novel Clostridial isolates with probiotic potential Deliverables Swift SM, Seal BS, Garrish JK, Oakley BB, Hiett K, Yeh HY, Woolsey R, Schegg KM, Line JE, Donovan DM. A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability. Viruses 2015, 7(6):3019-3034. Oakley BB, Kogut M, Donovan DD, Cox NA, Berrang ME, Chalghoumi R, Seal, BS. Managing the Gut Microbiome of Food Animals With Tools of Microbial Ecology. Poster presentation at IPC2015 meeting, Budapest, Hungary, June 21-23 2015. Title: Macrophage priming affects disease resistance and susceptibility in response to viral pathogens. Manuscript submitted: PLOS ONE: Irizarry KJ,*, Downs E, Bryden R, Clark J , Griggs L, Kopulos R, Boettger CM, Carr TJ Jr. , Keeler CL, Collisson E, Drechsler Y,**: RNA Sequencing Demonstrates Large-Scale Temporal Dysregulation of Gene Expression in Stimulated Macrophages Derived from MHC-Defined Chicken Haplotypes Abstract submitted: AAI 2016: Drechsler Y, Irizarry KJ, Downs E, Bryden R, Clark J , Griggs L, Kopulos R, Boettger CM, Carr TJ Jr. , Keeler CL, Collisson E: Global dysregulation of gene expression in macrophages from different haplotypes correlates with disease resistance Grants planned: USDA NIFA RFA 2016 (to be announced) What do you plan to do during the next reporting period to accomplish the goals? Nothing Reported

Impacts
What was accomplished under these goals? The two below projects represent the funded and completed projects during the 2014-2015 NIFA period per the goals of the overall project. Title: Genome sequencing of novel Clostridial isolates with probiotic potential PI: Brian Oakley Co-I(s): Dr. Raja Chalghoumi, Assistant Professor, Animal Science Department, University of Carthage, Tunisia Background The rationale for this project was based on recent data by the PI and others showing that bacteria belonging to the Clostridiales order are dominant members of the healthy chicken cecal microbiome. Members of our research team had previously embarked on a systematic approach to isolate and characterize novel strains of Clostridia occurring naturally with the healthy chicken GI tract for potential use as probiotics. A Fulbright fellow (Dr. Chalghoumi) visiting the PI's previous lab successfully brought into cultivation various members of the Clostridia from chicken ceca. The funding requested here was for two main purposes: 1) whole-genome sequencing of these strains, and 2) travel to an international scientific congress (IPC2015) on probiotics. As part of a larger research program by the PI to develop tools and strategies for managing the microbiota, this research met the mandates of Section 1433 funds by promoting general welfare through improved health and productivity of domestic poultry and reducing reliance on antibiotics as growth promoters. The genomic data made possible by this project is enabling characterization of these strains to facilitate their potential use as probiotics. Travel to the IPC2015 congress helped promote the project via interactions with the scientific community and presentation of results. Results Bacterial isolates previously obtained from the mid-gut and ceca of commercial broiler chickens were grown from freezer stocks and genomic DNA preparations sent for whole-genome sequencing at Retrogen. Genomic DNA was sequenced on an Illumina MiSeq instrument with 300 bp paired-end reads using the V3 reagant kit. Approximately 10.8 Gb of high-quality data (>=Q30) was obtained from the sequencing run. Following sequencing, data were further processed using standard genomics tools including trimmomatic, the fastx toolkit, flash, assembly with Velvet and Spades, and annotation with RAST. Most analyses are still underway, but we have obtained some preliminary results. Of the 48 isolates sequenced, at least two appear to represent novel species within Clostridium Cluster I based on preliminary genomic analyses. Genome sequencing of these two strains (N50 values of 129255 kb and 470109 kb respectively) has revealed several genes that may have commercial value as alternative antimicrobials, particularly several bacteriophage holin and endolysin genes. The sequences of these genes has not yet been published, but was used for comparative genomics in a related project with a peer-reviewed paper in 2015 as listed below. With many analyses of the large genomic data set still underway, we are targeting submission of a more comprehensive genomics manuscript in the 2016 calendar year. Title: Macrophage priming affects disease resistance and susceptibility in response to viral pathogens. PI: Drechsler, Yvonne Background and justification: Although the ultimate strategy for controlling viral and bacterial infections is to develop genetically resistant animals, the underlying molecular mechanisms conferring disease resistance are poorly understood. We have previously demonstrated that B2 haplotype birds resolved infectious bronchitis virus (IBV) infection in lungs, kidneys and trachea more readily than B19 infected chicks and showed less clinical illness (Banat et al. 2013). At least part of this difference can be explained by the consistently more vigorous responses of B2 macrophages to Poly IC and IFNg stimulation than responses of B19 derived macrophages (Dawes et al. 2014). Recent studies in mammalian and avian species have shown that priming or polarization of macrophages is a critical factor in shaping the immune response towards inflammation or tolerance/healing. Thus investigating the underlying mechanisms will significantly improve our understanding of the role of macrophages in disease resistance. Objectives and hypotheses: The overriding hypothesis is that polarization of macrophages is involved in disease resistance of chicken haplotypes in response to pathogens. Our overall goal is to identify unique markers or genes that are involved in polarization of chicken macrophages and determine the role of these markers in the "training" or priming of macrophages on disease resistance. Specific Objectives: Polarize macrophages in vitro and identify differential gene expression in B2 versus B19 macrophages Approach: The proposed goals will build on our recent and ongoing studies characterizing differences in peripheral macrophages in different B haplotype chickens. In the context of identifying mechanisms between resistance and susceptibility in birds, Macrophages will be stimulated in vitro with IFNg and IL-4 to polarize. Pathways including TLR signaling and adenosine receptor signaling will be further investigated with PCR. These genes were selected based on results obtained by RNA sequencing of stimulated macrophages from different B haplotypes. Potential impact: The proposed studies will be directly applicable to our capacity to identify, select and breed poultry on the basis of their resistance to respiratory viruses and defining mechanisms associated with polarization of macrophages may lead to better strategies to control and prevent disease and provide innovative, critical immunological tools. Results He et al. have shown that HD11 avian macrophage cells can be stimulated differentially by Th1 and Th2 cytokines IFNg, IL 4 and both cytokines were able to stimulate the chicken macrophage cell line HD-11 to produce nitric oxide. However, there are no studies currently published on characterization of M1 and M2 polarization of primary avian macrophages. We are currently establishing which genes and markers are upregulated when primed differentially in peripheral monocytes in response to Th1 and Th2 cytokines. We have stimulated macrophages from B2 and B19 haplotype chickens with IFNg and IL-4. While HD-11 controls showed some nitric oxide release after stimulation with both cytokines as shown by He et al., we have found that only IFNg stimulates the release of nitric oxide from B2 as well as B19 primary macrophages. IL-4 did not induce nitric oxide in any of the primary macrophages, which is more in line with the function of IL-4 as M2 cytokine. Macrophages have both iNOS and arginase enzymes that can convert arginine to NO or ornithine, respectively. Typically IFNg as M1 cytokine will induce NO production while IL-4 does not as previously shown in human, mouse and other macrophages. RNA has been collected from B2 and B19 macrophages stimulated with either IFNg or IL-4 for 0, 2 or 4 hours. Primers characterizing M1 vs M2 phenotypes have been established (IL1, IL6, IL12, HES-1, SOCS3, CD163, TGFb, IL-10, YM-1 and Mannose Receptor 1, VEGF) and Real-Time PCR performed. Data analysis is currently being done on preliminary results, with still more birds ordered to increase the sample size.

Publications

  • Type: Journal Articles Status: Published Year Published: 2015 Citation: Swift SM, Seal BS, Garrish JK, Oakley BB, Hiett K, Yeh HY, Woolsey R, Schegg KM, Line JE, Donovan DM. A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability. Viruses 2015, 7(6):3019-3034.
  • Type: Journal Articles Status: Published Year Published: 2015 Citation: Oakley BB, Kogut M, Donovan DD, Cox NA, Berrang ME, Chalghoumi R, Seal, BS. Managing the Gut Microbiome of Food Animals With Tools of Microbial Ecology. Poster presentation at IPC2015 meeting, Budapest, Hungary, June 21-23 2015.
  • Type: Journal Articles Status: Submitted Year Published: 2015 Citation: PLOS ONE: Irizarry KJ,*, Downs E, Bryden R, Clark J , Griggs L, Kopulos R, Boettger CM, Carr TJ Jr. , Keeler CL, Collisson E, Drechsler Y,**: RNA Sequencing Demonstrates Large-Scale Temporal Dysregulation of Gene Expression in Stimulated Macrophages Derived from MHC-Defined Chicken Haplotypes
  • Type: Conference Papers and Presentations Status: Submitted Year Published: 2015 Citation: Abstract submitted AAI 2016: Drechsler Y, Irizarry KJ, Downs E, Bryden R, Clark J , Griggs L, Kopulos R, Boettger CM, Carr TJ Jr. , Keeler CL, Collisson E: Global dysregulation of gene expression in macrophages from different haplotypes correlates with disease resistance